Financhill
Back

Zoetis 10K Form

Sell
27

ZTS
Zoetis

Last Price:
169.15
Seasonality Move:
9.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ZTS News And Ratings

See the #1 stock for the next 7 days that we like better than ZTS

ZTS Financial Statistics

Sales & Book Value

Annual Sales: $8.54B
Cash Flow: $699M
Price / Cash Flow: 48.16
Annual Sales: $10.90
Price / Book: 15.48

Profitability

EPS (TTM): 5.07000
Net Income (TTM): $2.34B
Gross Margin: $5.98B
Return on Equity: 49.7%
Return on Assets: 16.55%

Zoetis Earnings Forecast

Key Zoetis Financial Ratios

  • The Gross Profit Margin over the past 15 years for ZTS is 70.03%.
  • The Selling, General & Administrative Expenses for ZTS have been equal to 25.18% of Gross Profit Margin.
  • The Research & Development expenses have been 7.19% of Revenue.
  • The Interest Expense is 10.20% of Operating Income.
  • The Net Earning history of ZTS is 27.43% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 13 years.

Zoetis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Current Symbol: ZTS
CUSIP: 98978V
Website: zoetis.com

Debt

Debt-to-Equity Ratio: 1.31
Current Ratio: 3.36
Quick Ratio: 1.77

Price-to-Earnings

Trailing P/E Ratio: 33.31
Forward P/E Ratio: 26.08

ZTS Technical Analysis vs Fundamental Analysis

Sell
27
Zoetis (ZTS) is a Sell

Is Zoetis a Buy or a Sell?

  • Zoetis stock is rated a Sell
    The current Zoetis [ZTS] share price is $168.51. The Score for ZTS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.